How do you discuss harms of MGUS screening with other medical providers?
For example, how do you address tendency to "over-order" these tests in patients with common aches/pains but no structural abnormalities on advanced imaging? Or in patients with longstanding CKD that's not changing over years?
Answer from: Medical Oncologist at Academic Institution
I understand the intent of the question, but - as always - real life is more complicated. I agree that the evidence for screening completely healthy patients for MGUS does not currently exist. But, for patients with unexplained pertinent lab/imaging findings or symptoms, it's not unreasonable.
In t...
Comments
Medical Oncologist at Medical University of South Carolina Yes, it always comes to trade-offs between the soc...
Medical Oncologist at Kaiser Permanente Thank you very much for your insight, Dr. @Banerje...
Answer from: Medical Oncologist at Academic Institution
I agree with @Rahul Banerjee's wonderful answer here. The challenge is that most patients who come to see us have already had these tests performed. The bigger issue is that most non-hematologists ordering them do not know how to interpret them either.
Most of the time, in my experience, screening ...
Comments
Medical Oncologist at University of Washington, Fred Hutchinson Cancer Research Center Excellently said on all fronts! The other interest...
Yes, it always comes to trade-offs between the soc...
Thank you very much for your insight, Dr. @Banerje...